KRMD KORU Medical Systems Inc.

KORU Medical Systems Inc.

Medical/Dental Instruments

Health Care

Repro Med Systems, Inc., doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.

IPO Year:

Exchange: NASDAQ

Website: korumedical.com

Peers

$NBSE

$SACH

Recent Analyst Ratings for KORU Medical Systems Inc.

Date	Price Target	Rating	Analyst
2/14/2025	$4.50	Overweight → Neutral	Piper Sandler
7/25/2024	$4.00	Buy	B. Riley Securities
9/7/2023	$4.00	Buy	Lake Street
9/7/2023	$4.50	Buy	B. Riley Securities
11/10/2022	$3.00 → $4.00	Hold → Buy	Canaccord Genuity
11/10/2022	$3.00 → $3.50	Neutral → Overweight	Piper Sandler

See more ratings

KORU Medical Systems Inc.

Peers

Recent Analyst Ratings for KORU Medical Systems Inc.

KORU Medical Systems Inc. Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Manko Joseph M. Jr. disposed of 14,317 shares (SEC Form 4)

Chief Executive Officer Tharby Linda M covered exercise/tax liability with 23,587 shares, decreasing direct ownership by 2% to 1,023,163 units (SEC Form 4)

Director Wholihan Edward was granted 5,870 shares, increasing direct ownership by 21% to 33,583 units (SEC Form 4)

Director Matin Shahriar was granted 5,870 shares, increasing direct ownership by 8% to 83,415 units (SEC Form 4)

Director French Donna was granted 5,870 shares, increasing direct ownership by 8% to 80,785 units (SEC Form 4)

Chairman of the Board Fletcher R John was granted 8,806 shares, increasing direct ownership by 4% to 205,562 units (SEC Form 4)

Director Cascella Robert was granted 5,870 shares, increasing direct ownership by 8% to 80,426 units (SEC Form 4)

Director Manko Joseph M. Jr. was granted 5,870 shares (SEC Form 4)

Chief Executive Officer Tharby Linda M converted options into 15,968 shares and covered exercise/tax liability with 38,661 shares, decreasing direct ownership by 2% to 1,046,750 units (SEC Form 4)

Chief Operating Officer Pazdan Christopher converted options into 41,394 shares and covered exercise/tax liability with 14,490 shares, increasing direct ownership by 60% to 71,625 units (SEC Form 4)